CARsgen is working to transform outcomes for patients with solid tumors by advancing the potential of CAR T technologies
The collaboration gives Axolabs access to Codexis’ innovative RNA manufacturing technology
The company is rolling out ARTEMIS, a next-generation AI platform for capsid design
Artificial intelligence coupled with laboratory automation will transform how scientific work is performed
Backed by two CAP - accredited genomics labs in Delhi NCR and Mumbai, supporting oncology, reproductive health, neurology, transplant immunology, and rare diseases
The FDA has set a Prescription Drug User Fee Act (PDUFA) target action date of June 10, 2026
GRIN-NDD is one of the most complex neurodevelopmental disorders with limited treatment options today
Subscribe To Our Newsletter & Stay Updated